Intermediate filament proteins of the liver: Emerging disease association and functions

Hepatology

Volumn 25, Issue 5, 1997, Pages 1043-1048

  Omary, M Bishr ^a   Ku, Nam O N ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; INTERMEDIATE FILAMENT PROTEIN; KERATIN;

DISEASE PREDISPOSITION; EPIDERMOLYSIS BULLOSA SIMPLEX; GENE MUTATION; HUMAN; LIVER CELL; LIVER DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STRESS;

EID: 0030955612     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250537     Document Type: Review

References (26)

1. Porter KR. Observations on the submicroscopic structure of animal epidermis. Anat Rec 1954;118:433.
2. Ishikawa H, Bischoff R, Holtzer H. Mitosis and intermediate-sized filaments in developing skeletal muscle. J Cell Biol 1968;38:538-555.
3. Steinert PM, Roop DR. Molecular and cellular biology of intermediate filaments. Annu Rev Biochem 1988;57:593-625.
4. Fuchs E, Weber K. Intermediate filaments: structure, dynamics, function and disease. Annu Rev Biochem 1994;63:345-382.
5. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
6. Osborn M, Van Lessen G, Weber K, Kloppel G, Altmannsberger M. Methods in laboratory investigation: differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides. Lab Invest 1986;55:497-504.
7. Blouin R, Blouin M-J, Royal I, Grenier A, Roop DR, Loranger A, Marceau N. Cytokeratin 14 expression in rat liver cells in culture and localization in vivo. Differentiation 1992;52:45-54.
8. Rockey DC, Friedman SL. Cytoskeleton of liver perisinusoidal cells (lipocytes) in normal and pathological conditions. Cell Motil Cytoskel 1992;22: 227-234.
9. Van Eyken P, Desmet VJ. Cytokeratins and the liver. Liver 1993;13:113-122.
10. Marceau N, Loranger A. Cytokeratin expression, fibrillar organization, and subtle function in liver cells. Biochem Cell Biol 1995;73:619-625.
11. Cadrin M, Martinoli MG. Alterations of intermediate filaments in various histopathological conditions. Biochem Cell Biol 1995;73:627-634.
12. Klymkowsky MW, Miller RH, Lane EB. Morphology, behavior, and interaction of cultured epithelial cells after the antibody-induced disruption of keratin filament organization. J Cell Biol 1983;96:494-509.
13. Lin JJ-C, Feramisco JR. Disruption of the in vivo distribution of the intermediate filaments in fibroblasts through the microinjection of a specific monoclonal antibody. Cell 1981;24:185-193.
14. Vassar R, Coulombe PA, Degenstein L, Albers K, Fuchs E. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell 1991;64:365-380.
15. Coulombe PA, Hutton ME, Letai A, Hebert A, Paller AS, Fuchs E. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analysis. Cell 1991;66:1301-1311.
16. Fuchs E, Esteves RA, Coulombe PA. Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc Natl Acad Sci U S A 1992;89:6906-6910.
17. Fuchs E. Intermediate filaments and disease: mutations that cripple cell strength. J Cell Biol 1994;125:511-516.
18. Abe M, Oshima RG. A single human keratin 18 gene is expressed in diverse epithelial cells of transgenic mice. J Cell Biol 1990;111:1197-1206.
19. Bader BL, Franke WW. Cell type-specific and efficient synthesis of human cytokeratin 19 in transgenic mice. Differentiation 1990;45:109-118.
20. Oshima RG, Baribault H, Caulin C. Oncogenic regulation and function of keratins 8 and 18. Cancer Metastasis Rev 1996;15:445-471.
21. Casanova L, Bravo A, Were F, Ramirez A, Jorcano JJ, Vidal M. Tissue-specific and efficient expression of the human simple epithelial keratin 8 gene in transgenic mice. J Cell Sci 1995;108:811-820.
22. Ku N-O, Michie S, Oshima RG, Omary MB. Chronic hepatitis, hepatocyte fragility, and increased soluble phospboglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J Cell Biol 1995;131: 1303-1314.
23. Ku N-O, Michie SA, Soetikno RM, Resurreccion EZ, Broome RL, Oshima RG, Omary MB. Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant. J Clin Invest 1996;98:1034-1046.
24. Baribault H, Price J, Miyai K, Oshima RG. Mid-gestational lethality in mice lacking keratin 8. Genes Dev 1993;7:1191-1202.
25. Baribault H, Penner J, lozzo RV, Wilson-Heiner M. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev 1994;8: 2964-2973.
26. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 1995;269: 230-234.